PDF herunterladen
Facial Plast Surg 2018; 34(01): 075-081
DOI: 10.1055/s-0037-1617446
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Indications and Use of Isotretinoin in Facial Plastic Surgery

Markus V. Heppt   *
1   Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
,
Michael C. Kirchberger   *
2   Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany
,
Thomas Ruzicka
1   Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
,
Carola Berking
1   Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
,
Werner J. Heppt
3   Skin and Face Clinic, Baden-Baden, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
06. Februar 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Isotretinoin is a first generation retinoid with pleiotropic effects on keratinocyte differentiation, proliferation, and activity of sebaceous glands. For years, there has been intense debate on whether the use of isotretinoin combined with cosmetic or surgical procedures is safe and potentially more efficient than either therapy alone. Due to delays in wound healing and keloid formation, conservative recommendations were not to combine isotretinoin with any plastic surgery or local treatment at 6 to 12 months after discontinuation of the drug. However, there is increasing evidence that a combination approach is not only safe, but may also provide excellent cosmetic outcomes in acne scars, sebaceous gland hyperplasia, and thick-skinned patients undergoing facial plastic surgery. In particular, low-dose regimens of isotretinoin may offer advantages over standard dosage treatments because of better tolerability and safety in long-term use adjunct with surgical interventions. In this article, the authors aim to summarize the current evidence on the use of isotretinoin in facial plastic surgery and to share their experience from selected patients.

Keywords

isotretinoin - acne - scars - laser - facial plastic surgery

* Both authors have contributed equally to this article.


 

  • References

  • 1 Amann PM, Merk HF, Baron JM. [Retinoids in dermatopharmacology]. Hautarzt 2014; 65 (02) 98-105
    CrossrefPubMedSuche in Google Scholar
  • 2 Bruno NP, Beacham BE, Burnett JW. Adverse effects of isotretinoin therapy. Cutis 1984; 33 (05) 484-486, 489
    PubMedSuche in Google Scholar
  • 3 Wootton CI, Cartwright RP, Manning P, Williams HC. Should isotretinoin be stopped prior to surgery? A critically appraised topic. Br J Dermatol 2014; 170 (02) 239-244
    CrossrefPubMedSuche in Google Scholar
  • 4 Sharma J, Thiboutot DM, Zaenglein AL. The effects of isotretinoin on wisdom tooth extraction. J Am Acad Dermatol 2012; 67 (04) 794-795
    CrossrefPubMedSuche in Google Scholar
  • 5 Ungarelli LF, Hetem CM, Farina Junior JA. Is it safe to operate on patients taking isotretinoin?. Aesthetic Plast Surg 2016; 40 (01) 139-148
    CrossrefPubMedSuche in Google Scholar
  • 6 On SC, Zeichner J. Isotretinoin updates. Dermatol Ther (Heidelb) 2013; 26 (05) 377-389
    CrossrefPubMedSuche in Google Scholar
  • 7 Cobo R, Vitery L. Isotretinoin use in thick-skinned rhinoplasty patients. Facial Plast Surg 2016; 32 (06) 656-661
    Thieme ConnectPubMedSuche in Google Scholar
  • 8 Amichai B, Shemer A, Grunwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol 2006; 54 (04) 644-646
    CrossrefPubMedSuche in Google Scholar
  • 9 Lee JW, Yoo KH, Park KY. , et al. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. Br J Dermatol 2011; 164 (06) 1369-1375
    CrossrefPubMedSuche in Google Scholar
  • 10 Mehra T, Borelli C, Burgdorf W, Röcken M, Schaller M. Treatment of severe acne with low-dose isotretinoin. Acta Derm Venereol 2012; 92 (03) 247-248
    CrossrefPubMedSuche in Google Scholar
  • 11 Sardana K, Garg VK. Low-dose isotretinoin in acne vulgaris: a critical review. Br J Dermatol 2011; 165 (03) 698-700
    CrossrefPubMedSuche in Google Scholar
  • 12 Palmer RA, Sidhu S, Goodwin PG. ‘Microdose’ isotretinoin. Br J Dermatol 2000; 143 (01) 205-206
    CrossrefPubMedSuche in Google Scholar
  • 13 Sehgal VN, Srivastava G, Aggarwal AK, Sardana K, Jain M. Efficacy of isotretinoin in pityriasis rubra pilaris: unapproved use. Int J Dermatol 2006; 45 (10) 1238-1240
    CrossrefPubMedSuche in Google Scholar
  • 14 Sehgal VN, Srivastava G, Sardana K. Isotretinoin--unapproved indications/uses and dosage: a physician's reference. Int J Dermatol 2006; 45 (06) 772-777
    CrossrefPubMedSuche in Google Scholar
  • 15 Warren EW, Khanderia U. Use of retinoids in the treatment of psoriasis. Clin Pharm 1989; 8 (05) 344-351
    PubMedSuche in Google Scholar
  • 16 Segurado-Miravalles G, Camacho-Martínez FM, Arias-Santiago S. , et al. Epidemiology, clinical presentation and therapeutic approach in a multicentre series of dissecting cellulitis of the scalp. J Eur Acad Dermatol Venereol 2017; 31 (04) e199-e200
    CrossrefPubMedSuche in Google Scholar
  • 17 Tietze JK, Heppt MV, von Preußen A. , et al. Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients. J Eur Acad Dermatol Venereol 2015; 29 (09) 1816-1821
    CrossrefPubMedSuche in Google Scholar
  • 18 Bjellerup M, Wallengren J. Familial perifolliculitis capitis abscedens et suffodiens in two brothers successfully treated with isotretinoin. J Am Acad Dermatol 1990; 23 (4 Pt 1): 752-753
    CrossrefPubMedSuche in Google Scholar
  • 19 Rademaker M. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?. Australas J Dermatol 2013; 54 (03) 157-162
    CrossrefPubMedSuche in Google Scholar
  • 20 Kar BR, Tripathy S, Panda M. Comparative study of oral isotretinoin versus oral isotretinoin + 20% salicylic acid peel in the treatment of active acne. J Cutan Aesthet Surg 2013; 6 (04) 204-208
    CrossrefPubMedSuche in Google Scholar
  • 21 Picosse FR, Yarak S, Cabral NC, Bagatin E. Early chemabrasion for acne scars after treatment with oral isotretinoin. Dermatol Surg 2012; 38 (09) 1521-1526
    CrossrefPubMedSuche in Google Scholar
  • 22 Hernandez-Perez E, Khawaja HA, Alvarez TY. Oral isotretinoin as part of the treatment of cutaneous aging. Dermatol Surg 2000; 26 (07) 649-652
    CrossrefPubMedSuche in Google Scholar
  • 23 Mahadevappa OH, Mysore V, Viswanath V. , et al. Surgical outcome in patients taking concomitant or recent intake of oral isotretinoin: a multicentric Study-ISO-AIMS Study. J Cutan Aesthet Surg 2016; 9 (02) 106-114
    CrossrefPubMedSuche in Google Scholar
  • 24 Spring LK, Krakowski AC, Alam M. , et al. Isotretinoin and timing of procedural interventions: a systematic review with consensus recommendations. JAMA Dermatol 2017; 153 (08) 802-809
    CrossrefPubMedSuche in Google Scholar
  • 25 Waldman A, Bolotin D, Arndt KA. , et al. ASDS guidelines task force: consensus recommendations regarding the safety of lasers, dermabrasion, chemical peels, energy devices, and skin surgery during and after isotretinoin use. Dermatol Surg 2017; 43 (10) 1249-1262
    CrossrefPubMedSuche in Google Scholar
  • 26 Saluja SS, Walker ML, Summers EM, Tristani-Firouzi P, Smart DR. Safety of non-ablative fractional laser for acne scars within 1 month after treatment with oral isotretinoin: a randomized split-face controlled trial. Lasers Surg Med 2017
    PubMed
  • 27 Yoon JH, Park EJ, Kwon IH. , et al. Concomitant use of an infrared fractional laser with low-dose isotretinoin for the treatment of acne and acne scars. J Dermatolog Treat 2014; 25 (02) 142-146
    CrossrefPubMedSuche in Google Scholar
  • 28 Bernestein LJ, Geronemus RG. Keloid formation with the 585-nm pulsed dye laser during isotretinoin treatment. Arch Dermatol 1997; 133 (01) 111-112
    PubMedSuche in Google Scholar
  • 29 Khatri KA, Iqbal N, Bhawan J. Laser skin resurfacing during isotretinoin therapy. Dermatol Surg 2015; 41 (06) 758-759
    CrossrefPubMedSuche in Google Scholar
  • 30 Kim HW, Chang SE, Kim JE, Ko JY, Ro YS. The safe delivery of fractional ablative carbon dioxide laser treatment for acne scars in Asian patients receiving oral isotretinoin. Dermatol Surg 2014; 40 (12) 1361-1366
    CrossrefPubMedSuche in Google Scholar
  • 31 Noh S, Shin JU, Jung JY, Lee JH. A case of sebaceous hyperplasia maintained on low-dose isotretinoin after carbon dioxide laser treatment. Int J Dermatol 2014; 53 (02) e151-e153
    CrossrefPubMedSuche in Google Scholar
  • 32 Park HC, Kim EJ, Kim JE, Ro YS, Ko JY. Treatment of multiple eccrine hidrocystomas with isotretinoin followed by carbon dioxide laser. J Dermatol 2013; 40 (05) 414-415
    CrossrefPubMedSuche in Google Scholar
  • 33 Roenigk Jr HH, Pinski JB, Robinson JK, Hanke CW. Acne, retinoids, and dermabrasion. J Dermatol Surg Oncol 1985; 11 (04) 396-398
    CrossrefPubMedSuche in Google Scholar
  • 34 Rubenstein R, Roenigk Jr HH, Stegman SJ, Hanke CW. Atypical keloids after dermabrasion of patients taking isotretinoin. J Am Acad Dermatol 1986; 15 (2 Pt 1): 280-285
    CrossrefPubMedSuche in Google Scholar
  • 35 Zachariae H. Delayed wound healing and keloid formation following argon laser treatment or dermabrasion during isotretinoin treatment. Br J Dermatol 1988; 118 (05) 703-706
    CrossrefPubMedSuche in Google Scholar
  • 36 Katz BE, Mac Farlane DF. Atypical facial scarring after isotretinoin therapy in a patient with previous dermabrasion. J Am Acad Dermatol 1994; 30 (5 Pt 2): 852-853
    CrossrefPubMedSuche in Google Scholar
  • 37 Bagatin E, dos Santos Guadanhim LR, Yarak S, Kamamoto CS, de Almeida FA. Dermabrasion for acne scars during treatment with oral isotretinoin. Dermatol Surg 2010; 36 (04) 483-489
    CrossrefPubMedSuche in Google Scholar
  • 38 Jansen T, Plewig G. Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg 1998; 14 (04) 241-253
    Thieme ConnectPubMedSuche in Google Scholar
  • 39 Allen BC, Rhee JS. Complications associated with isotretinoin use after rhinoplasty. Aesthetic Plast Surg 2005; 29 (02) 102-106
    CrossrefPubMedSuche in Google Scholar
  • 40 Guyuron B, Lee M. An effective algorithm for management of noses with thick skin. Aesthetic Plast Surg 2017; 41 (02) 381-387
    CrossrefPubMedSuche in Google Scholar
  • 41 Fiallo P. Reduced therapeutic activity of warfarin during treatment with oral isotretinoin. Br J Dermatol 2004; 150 (01) 164
    PubMedSuche in Google Scholar
  • 42 Ostlere LS, Langtry JA, Jones S, Staughton RC. Reduced therapeutic effect of warfarin caused by etretinate. Br J Dermatol 1991; 124 (05) 505
    PubMedSuche in Google Scholar
  • 43 DiGiovanna JJ. Isotretinoin effects on bone. J Am Acad Dermatol 2001; 45 (05) S176-S182
    CrossrefPubMedSuche in Google Scholar
  • 44 Trauner MA, Ruben BS. Isotretinoin induced rhabdomyolysis? A case report. Dermatol Online J 1999; 5 (02) 2
    PubMedSuche in Google Scholar
  • 45 Kaymak Y. Creatine phosphokinase values during isotretinoin treatment for acne. Int J Dermatol 2008; 47 (04) 398-401
    CrossrefPubMedSuche in Google Scholar
  • 46 Layton A. The use of isotretinoin in acne. Dermatoendocrinol 2009; 1 (03) 162-169
    CrossrefPubMedSuche in Google Scholar